Outlook Therapeutics, Inc. (OTLK) has received a notice of non-compliance from The Nasdaq Stock Market for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. The notice has no immediate effect on the company's stock listing on the Nasdaq Capital Market.
Key Details
- Compliance Issue: The company's common stock closed below the $1.00 per share minimum required by Nasdaq Listing Rule 5550(a)(2) for 30 consecutive business days.
- Compliance Period: Outlook Therapeutics has a 180-day grace period, until March 24, 2027, to regain compliance.
- Resolution Requirement: To regain compliance, the company's stock must achieve a closing bid price of at least $1.00 for a minimum of ten consecutive business days before the deadline. The company may be eligible for an additional 180-day period if certain conditions are met.